🔎 Trials Near Me

Početna › Migrena › Michigan

Kliničke studije za Migrena u državi Michigan

6 studija za Migrena traži sudionike na lokacijama u državi Michigan.

Gradovi u državi Michigan

Službeni tekst studije (engleski)

Study of EVO756 in Adults With Migraine

  • Michigan Headache and Neurological Institute, Ann Arbor
  • Quest Research Institute-Alcanza, Farmington Hills
U tijeku regrutacijaFaza 2
Od 18 do 64 godina · Oba spola · Ažurirano 2. lis 2026. · NCT07616128

Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

  • NRST - Detroit, Detroit
U tijeku regrutacijaFaza 3
Od 6 do 17 godina · Oba spola · Ažurirano 28. ruj 2026. · NCT05156398

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

  • Michigan Head Pain and Neurological Institute, Ann Arbor
  • Corewell Health, for and on behalf of Spectrum Health Hospital and Corewell Health Medical Group, Grand Rapids
  • Corewell Health, Helen DeVos Children's Hospital, Grand Rapids
  • i još 1
U tijeku regrutacijaFaza 3
Od 6 do 17 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT04743141

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

  • Michigan Head Pain & Neurological Institute, Ann Arbor
  • Corewell Health, for and on behalf of Spectrum Health Hospital and Corewell Health Medical Group, Grand Rapids
  • Corewell Health, Helen DeVos Children's Hospital, Grand Rapids
  • i još 1
U tijeku regrutacijaFaza 3
Od 6 do 17 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT04649242

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

  • Michigan Headache & Neurological Institute /ID# 270942, Ann Arbor
U tijeku regrutacijaFaza 3
Od 12 do 17 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT06810505

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

  • Michigan Headache Pain & Neurological Institute, Ann Arbor
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 20. kol 2026. · NCT07645924

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.